Cargando…

Pro Re Nata Use of Psychotropic Medications in Assisted Living

This study examined the use of pro re nata (PRN, or as needed) psychotropic medications among assisted living (AL) residents. We examined prescriptions and administrations, and compared use based on dementia diagnosis. Data sources included interviews with administrators of 250 AL communities in 7 s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Carder, Paula, Zimmerman, Sheryl, Wretman, Christopher, Dys, Sarah, Sloane, Philip
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7742550/ http://dx.doi.org/10.1093/geroni/igaa057.2482

Ejemplares similares

Antipsychotic and Psychotropic Prescribing in Assisted Living
por: Zimmerman, Sheryl, et al.
Publicado: (2020)

Seven-State Study of Assisted Living and Healthcare Providers’ Responses to COVID-19
por: Zimmerman, Sheryl, et al.
Publicado: (2021)

EXPERT CONSENSUS PANEL RECOMMENDATIONS FOR MEDICAL AND MENTAL HEALTH CARE IN ASSISTED LIVING
por: Zimmerman, Sheryl, et al.
Publicado: (2022)

Local Nursing Home Prescribing Patterns and Psychoactive Prescribing in Assisted Living
por: Thomas, Kali, et al.
Publicado: (2020)

Off-Label Antipsychotic Prescribing for Persons With Dementia in Assisted Living
por: Wretman, Christopher, et al.
Publicado: (2020)

COVID-19 Response In U.S. Assisted Living Settings: Key Stakeholder Perspectives
por: Dys, Sarah, et al.
Publicado: (2021)

Implementing Psychosocial and Environmental Practices for Persons With Dementia in Assisted Living
por: Schwartz, Lindsay, et al.
Publicado: (2020)

Melatonin Use for Sleep in Assisted Living
por: Peketi, Punita, et al.
Publicado: (2020)

Which Assisted Living Communities Provide Hospice?
por: Prizer, Lindsay, et al.
Publicado: (2020)

“Doing the Impossible with the Inadequate”: COVID-19 Response in U.S. Assisted Living Settings
por: Dys, Sarah, et al.
Publicado: (2020)

Potential Antipsychotic Side Effects and Adverse Events of Assisted Living Residents With Dementia
por: Beeber, Anna, et al.
Publicado: (2020)

State Regulatory Response to COVID-19 Limited Assisted Living Resident Caregiver Networks
por: Smith, Lindsey, et al.
Publicado: (2021)

Excess Mortality Attributable to COVID-19 Among Assisted Living Residents
por: Thomas, Kali, et al.
Publicado: (2021)

A Typology of Health Services Regulated in U.S. Assisted Living Communities
por: Carder, Paula, et al.
Publicado: (2021)

ANTIPSYCHOTIC MEDICATION USE IN ASSISTED LIVING/RESIDENTIAL CARE: DO ORGANIZATIONAL CHARACTERISTICS MATTER?
por: Dys, Sarah, et al.
Publicado: (2022)

The use and effectiveness of pro re nata psychotropic medications in children and adolescents: A systematic review
por: Asogwa, Kenneth, et al.
Publicado: (2017)

Experiences of Rural and Urban Assisted Living Communities in Oregon During COVID-19 Pandemic
por: Tunalilar, Ozcan, et al.
Publicado: (2021)

Influence of Psychotropic Pro Re Nata Drug Use on Outcomes in Hospitalized Patients with Schizophrenia
por: Kyou, Yoshitaka, et al.
Publicado: (2023)

The monitoring and use of Pro re nata (PRN) psychotropic medication for people with learning disabilities on an inpatient ward
por: Mistry, Heena
Publicado: (2021)

Psychoactive Prescribing in Assisted Living
por: Zimmerman, Sheryl, et al.
Publicado: (2020)

COVID-19 Perspectives of Assisted Living and Health Care Providers in Seven States
por: Zimmerman, Sheryl, et al.
Publicado: (2021)

Assisted Living Care for Special Populations
por: Sloane, Philip, et al.
Publicado: (2020)

Coronavirus Disease 2019 Regulatory Response in United States-Assisted Living Communities: Lessons Learned
por: Dys, Sarah, et al.
Publicado: (2021)

Audit on use of PRN (pro re nata) psychotropic medication for behavioural disturbance in individuals with intellectual disability in the community
por: Dhandapani, Asha, et al.
Publicado: (2021)

Beyond the Medication Pass: Attitudes, Ethics, Agency, and Antipsychotic Medications in Assisted Living/Residential Care
por: Dys, Sarah, et al.
Publicado: (2022)

Use of Psychotropic “Pro Re Nata” Medications by Patients Attending the Outpatient Clinic in a Hospital: A Qualitative Exploration
por: Rajiah, Kingston, et al.
Publicado: (2021)

REIMAGINING POLICY-INFORMED RESEARCH FOR THE FUTURE OF ASSISTED LIVING
por: Carder, Paula, et al.
Publicado: (2022)

COVID-19 Recommendations for Assisted Living: Implications for the Future
por: Vipperman, Andrew, et al.
Publicado: (2021)

A VISION FOR THE FUTURE OF ASSISTED LIVING RESEARCH: LEVERAGING ADMINISTRATIVE DATA TO STUDY QUALITY
por: Thomas, Kali, et al.
Publicado: (2022)

TRENDS IN MENTAL ILLNESS ACROSS ASSISTED LIVING SETTINGS: RESIDENT AND COMMUNITY FACTORS
por: Carlson, Bryant, et al.
Publicado: (2022)

Medical and Mental Health Services in US Assisted Living Settings During COVID-19: Challenges and Opportunities
por: Dys, Sarah, et al.
Publicado: (2021)

HOW STATES CHANGED REGULATORY REQUIREMENTS FOR ASSISTED LIVING STAFF SINCE 2003
por: Carder, Paula, et al.
Publicado: (2019)

How Assisted Living Staff Conceive of Dementia Care
por: Dobbs, Debra, et al.
Publicado: (2020)

Medical and Mental Health Care Challenges in Nursing Homes, Assisted Living, and Programs of All-Inclusive Care for the Elderly (PACE) During COVID-19
por: Zimmerman, Sheryl, et al.
Publicado: (2022)

Estimation of Excess Mortality Rates Among US Assisted Living Residents During the COVID-19 Pandemic
por: Thomas, Kali S., et al.
Publicado: (2021)

Potential Side Effects and Adverse Events of Antipsychotic Use for Residents With Dementia in Assisted Living: Implications for Prescribers, Staff, and Families
por: Beeber, Anna Song, et al.
Publicado: (2021)

Revisiting the Role of Physicians in Assisted Living and Residential Care Settings
por: Dys, Sarah, et al.
Publicado: (2020)

Pro Re Nata Prescription and Perception Difference between Doctors and Nurses
por: Oh, Se Hwa, et al.
Publicado: (2014)

Initial Pro Re Nata Brolucizumab for Exudative AMD: The PROBE Study
por: Bilgic, Alper, et al.
Publicado: (2021)

Patient Safety and Pro Re Nata Prescription and Administration: A Systematic Review
por: Vaismoradi, Mojtaba, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_fl40bt8n3suffu389gnb8rml9c